156 related articles for article (PubMed ID: 8996264)
1. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel.
Miller BH; Shavin JS; Cognetta A; Taylor RJ; Salasche S; Korey A; Orenberg EK
J Am Acad Dermatol; 1997 Jan; 36(1):72-7. PubMed ID: 8996264
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma.
Kraus S; Miller BH; Swinehart JM; Shavin JS; Georgouras KE; Jenner DA; Griffin E; Korey A; Orenberg EK
J Am Acad Dermatol; 1998 Mar; 38(3):438-42. PubMed ID: 9520026
[TBL] [Abstract][Full Text] [Related]
3. Development of intralesional therapy with fluorouracil/adrenaline injectable gel for management of condylomata acuminata: two phase II clinical studies.
Swinehart JM; Skinner RB; McCarty JM; Miller BH; Tyring SK; Korey A; Orenberg EK
Genitourin Med; 1997 Dec; 73(6):481-7. PubMed ID: 9582466
[TBL] [Abstract][Full Text] [Related]
4. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma.
Orenberg EK; Miller BH; Greenway HT; Koperski JA; Lowe N; Rosen T; Brown DM; Inui M; Korey AG; Luck EE
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):723-8. PubMed ID: 1430394
[TBL] [Abstract][Full Text] [Related]
5. Intralesional fluorouracil/epinephrine injectable gel for treatment of condylomata acuminata. A phase 3 clinical study.
Swinehart JM; Sperling M; Phillips S; Kraus S; Gordon S; McCarty JM; Webster GF; Skinner R; Korey A; Orenberg EK
Arch Dermatol; 1997 Jan; 133(1):67-73. PubMed ID: 9006374
[TBL] [Abstract][Full Text] [Related]
6. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY
Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573
[TBL] [Abstract][Full Text] [Related]
7. High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas.
Gupta AK; Turnbull DH; Foster FS; Harasiewicz KA; Shum DT; Prussick R; Watteel GN; Hurst LN; Sauder DN
Dermatol Surg; 1996 Feb; 22(2):131-6. PubMed ID: 8608374
[TBL] [Abstract][Full Text] [Related]
8. 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction.
Gross K; Kircik L; Kricorian G
Dermatol Surg; 2007 Apr; 33(4):433-9; discussion 440. PubMed ID: 17430377
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice.
Yu NY; Orenberg EK; Luck EE; Brown DM
Cancer Chemother Pharmacol; 1995; 36(1):27-34. PubMed ID: 7720172
[TBL] [Abstract][Full Text] [Related]
10. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
[TBL] [Abstract][Full Text] [Related]
11. Intralesional sustained-release chemotherapy with therapeutic implants for treatment of canine sun-induced squamous cell carcinoma.
Kitchell BK; Orenberg EK; Brown DM; Hutson C; Ray K; Woods L; Luck E
Eur J Cancer; 1995 Nov; 31A(12):2093-8. PubMed ID: 8562171
[TBL] [Abstract][Full Text] [Related]
12. Tumors of the skin. VI. Study on effects of local administration of 5-fluorouracil in basal cell carcinoma.
Klein E; Stoll HL; Milgrom H; Traenkle HL; Graham S; Helm F
J Invest Dermatol; 1966 Aug; 47(1):22-6. PubMed ID: 25622345
[TBL] [Abstract][Full Text] [Related]
13. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
Naik MP; Mehta A; Abrol S; Kumar S; Gupta VS
Orbit; 2016 Dec; 35(6):352-354. PubMed ID: 27715359
[TBL] [Abstract][Full Text] [Related]
14. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma.
Glass LF; Jaroszeski M; Gilbert R; Reintgen DS; Heller R
J Am Acad Dermatol; 1997 Oct; 37(4):596-9. PubMed ID: 9344200
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.
Leung TW; Yu S; Johnson PJ; Geschwind J; Vogl TJ; Engelmann K; Gores GJ; Giovannini M; O'Grady J; Heneghan M; Stewart M; Orenberg EK; Thuluvath PJ
J Clin Oncol; 2003 Feb; 21(4):652-8. PubMed ID: 12586802
[TBL] [Abstract][Full Text] [Related]
16. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
17. Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas.
Gyurova MS; Stancheva MZ; Arnaudova MN; Yankova RK
Dermatol Online J; 2006 Mar; 12(3):25. PubMed ID: 16638439
[TBL] [Abstract][Full Text] [Related]
18. Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil.
Morse LG; Kendrick C; Hooper D; Ward H; Parry E
Dermatol Surg; 2003 Nov; 29(11):1150-3; discussion 1153. PubMed ID: 14641346
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
20. Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged.
Cartei G; Cartei F; Interlandi G; Meneghini G; Jop A; Zingone G; Tabaro G; Mazzoleni F
Am J Clin Oncol; 2000 Apr; 23(2):181-4. PubMed ID: 10776981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
